AKT1 and breast carcinoma: In all three tested breast cancer cell lines, AQP5 overexpression did not activate the PI3K/AKT signaling pathway, as evidenced by the lack of an increase in phosphorylated AKT or the pAKT/AKT ratio (Figure 5A–C).